These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 14695140

  • 1. Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features.
    Sathyanarayana UG, Padar A, Suzuki M, Maruyama R, Shigematsu H, Hsieh JT, Frenkel EP, Gazdar AF.
    Clin Cancer Res; 2003 Dec 15; 9(17):6395-400. PubMed ID: 14695140
    [Abstract] [Full Text] [Related]

  • 2. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF.
    Clin Cancer Res; 2003 Dec 15; 9(17):6389-94. PubMed ID: 14695139
    [Abstract] [Full Text] [Related]

  • 3. Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.
    Padar A, Sathyanarayana UG, Suzuki M, Maruyama R, Hsieh JT, Frenkel EP, Minna JD, Gazdar AF.
    Clin Cancer Res; 2003 Oct 15; 9(13):4730-4. PubMed ID: 14581343
    [Abstract] [Full Text] [Related]

  • 4. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.
    Maruyama R, Toyooka S, Toyooka KO, Virmani AK, Zöchbauer-Müller S, Farinas AJ, Minna JD, McConnell J, Frenkel EP, Gazdar AF.
    Clin Cancer Res; 2002 Feb 15; 8(2):514-9. PubMed ID: 11839671
    [Abstract] [Full Text] [Related]

  • 5. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH, Lee S, Lee HJ, Hwang KS.
    J Pathol; 2004 Feb 15; 202(2):233-40. PubMed ID: 14743506
    [Abstract] [Full Text] [Related]

  • 6. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.
    Ii M, Yamamoto H, Taniguchi H, Adachi Y, Nakazawa M, Ohashi H, Tanuma T, Sukawa Y, Suzuki H, Sasaki S, Imai K, Shinomura Y.
    Int J Oncol; 2011 Sep 15; 39(3):593-9. PubMed ID: 21617852
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic inactivation of laminin-5-encoding genes in lung cancers.
    Sathyanarayana UG, Toyooka S, Padar A, Takahashi T, Brambilla E, Minna JD, Gazdar AF.
    Clin Cancer Res; 2003 Jul 15; 9(7):2665-72. PubMed ID: 12855645
    [Abstract] [Full Text] [Related]

  • 8. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.
    Clin Cancer Res; 2005 Sep 15; 11(18):6582-8. PubMed ID: 16166436
    [Abstract] [Full Text] [Related]

  • 9. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R, Ferdinand L, Reis IM, Schlesselman JJ.
    Oncol Rep; 2004 Sep 15; 12(3):631-7. PubMed ID: 15289848
    [Abstract] [Full Text] [Related]

  • 10. Aberrant up-regulation of LAMB3 and LAMC2 by promoter demethylation in gastric cancer.
    Kwon OH, Park JL, Kim M, Kim JH, Lee HC, Kim HJ, Noh SM, Song KS, Yoo HS, Paik SG, Kim SY, Kim YS.
    Biochem Biophys Res Commun; 2011 Mar 25; 406(4):539-45. PubMed ID: 21345334
    [Abstract] [Full Text] [Related]

  • 11. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
    Henrique R, Jerónimo C, Hoque MO, Nomoto S, Carvalho AL, Costa VL, Oliveira J, Teixeira MR, Lopes C, Sidransky D.
    Cancer Epidemiol Biomarkers Prev; 2005 May 25; 14(5):1274-8. PubMed ID: 15894685
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HRK inactivation associated with promoter methylation and LOH in prostate cancer.
    Higuchi T, Nakamura M, Shimada K, Ishida E, Hirao K, Konishi N.
    Prostate; 2008 Jan 01; 68(1):105-13. PubMed ID: 18008329
    [Abstract] [Full Text] [Related]

  • 14. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
    Lin SY, Yeh KT, Chen WT, Chen HC, Chen ST, Chiou HY, Chang JG.
    Oncol Rep; 2004 Feb 01; 11(2):341-8. PubMed ID: 14719065
    [Abstract] [Full Text] [Related]

  • 15. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W, Westra WH, Sidransky D.
    J Clin Oncol; 2005 Sep 20; 23(27):6569-75. PubMed ID: 16170165
    [Abstract] [Full Text] [Related]

  • 16. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS, Kim MJ, Lee JY, Kim YZ, Kim EJ, Park JY.
    Cancer; 2007 Dec 15; 110(12):2785-92. PubMed ID: 17960794
    [Abstract] [Full Text] [Related]

  • 17. Hypermethylation of the GATA genes in lung cancer.
    Guo M, Akiyama Y, House MG, Hooker CM, Heath E, Gabrielson E, Yang SC, Han Y, Baylin SB, Herman JG, Brock MV.
    Clin Cancer Res; 2004 Dec 01; 10(23):7917-24. PubMed ID: 15585625
    [Abstract] [Full Text] [Related]

  • 18. High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients.
    Henrique R, Ribeiro FR, Fonseca D, Hoque MO, Carvalho AL, Costa VL, Pinto M, Oliveira J, Teixeira MR, Sidransky D, Jerónimo C.
    Clin Cancer Res; 2007 Oct 15; 13(20):6122-9. PubMed ID: 17947477
    [Abstract] [Full Text] [Related]

  • 19. Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes.
    Sathyanarayana UG, Maruyama R, Padar A, Suzuki M, Bondaruk J, Sagalowsky A, Minna JD, Frenkel EP, Grossman HB, Czerniak B, Gazdar AF.
    Cancer Res; 2004 Feb 15; 64(4):1425-30. PubMed ID: 14973053
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, von Ruecker A.
    Clin Cancer Res; 2005 Jun 01; 11(11):4097-106. PubMed ID: 15930345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.